gentamicin and sparfloxacin

gentamicin has been researched along with sparfloxacin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrett, MS; Erwin, ME; Jones, RN; Koontz, FP1
Donabedian, SA; Perri, MB; Thal, LA; Vazquez, J; Zervos, MJ1
Charet, JC; Watine, J1
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P; Sambatakou, H1
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR1

Other Studies

5 other study(ies) available for gentamicin and sparfloxacin

ArticleYear
CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
    Diagnostic microbiology and infectious disease, 1992, Volume: 15, Issue:2

    Topics: Anti-Bacterial Agents; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium chelonae; Nontuberculous Mycobacteria; Quinolones

1992
Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:5

    Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gentamicins; Gram-Positive Bacterial Infections; Quinolones; Rabbits; Random Allocation

1993
[Bactericidal activity of quinolones (including sparfloxacin) against Enterococcus; in vitro antagonisms with gentamicin].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Anti-Infective Agents; Drug Antagonism; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Quinolones

1997
In vitro activity of quinupristin/dalfopristin and newer quinolones combined with gentamicin against resistant isolates of Enterococcus faecalis and Enterococcus faecium.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Virginiamycin

1998
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin

1999